163 related articles for article (PubMed ID: 22064320)
1. A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein.
Yimin ; Furumaki H; Matsuoka S; Sakurai T; Kohanawa M; Zhao S; Kuge Y; Tamaki N; Chiba H
Lab Invest; 2012 Feb; 92(2):265-81. PubMed ID: 22064320
[TBL] [Abstract][Full Text] [Related]
2. Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice.
Bieghs V; van Gorp PJ; Walenbergh SM; Gijbels MJ; Verheyen F; Buurman WA; Briles DE; Hofker MH; Binder CJ; Shiri-Sverdlov R
Hepatology; 2012 Sep; 56(3):894-903. PubMed ID: 22334337
[TBL] [Abstract][Full Text] [Related]
3. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.
Lo L; McLennan SV; Williams PF; Bonner J; Chowdhury S; McCaughan GW; Gorrell MD; Yue DK; Twigg SM
J Hepatol; 2011 Aug; 55(2):435-44. PubMed ID: 21184785
[TBL] [Abstract][Full Text] [Related]
4. Electronegative LDL is linked to high-fat, high-cholesterol diet-induced nonalcoholic steatohepatitis in hamsters.
Lai YS; Yang TC; Chang PY; Chang SF; Ho SL; Chen HL; Lu SC
J Nutr Biochem; 2016 Apr; 30():44-52. PubMed ID: 27012620
[TBL] [Abstract][Full Text] [Related]
5. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.
Wouters K; van Gorp PJ; Bieghs V; Gijbels MJ; Duimel H; Lütjohann D; Kerksiek A; van Kruchten R; Maeda N; Staels B; van Bilsen M; Shiri-Sverdlov R; Hofker MH
Hepatology; 2008 Aug; 48(2):474-86. PubMed ID: 18666236
[TBL] [Abstract][Full Text] [Related]
6. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
7. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
Kubota N; Kado S; Kano M; Masuoka N; Nagata Y; Kobayashi T; Miyazaki K; Ishikawa F
Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):422-30. PubMed ID: 23611112
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis.
Jeftic I; Jovicic N; Pantic J; Arsenijevic N; Lukic ML; Pejnovic N
Mol Med; 2015 May; 21(1):453-65. PubMed ID: 26018806
[TBL] [Abstract][Full Text] [Related]
9. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
10. Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation.
Nagano J; Shimizu M; Hara T; Shirakami Y; Kochi T; Nakamura N; Ohtaki H; Ito H; Tanaka T; Tsurumi H; Saito K; Seishima M; Moriwaki H
PLoS One; 2013; 8(9):e73404. PubMed ID: 24039933
[TBL] [Abstract][Full Text] [Related]
11. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
12. Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax.
Wang Y; Ausman LM; Russell RM; Greenberg AS; Wang XD
J Nutr; 2008 Oct; 138(10):1866-71. PubMed ID: 18806094
[TBL] [Abstract][Full Text] [Related]
13. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.
Subramanian S; Goodspeed L; Wang S; Kim J; Zeng L; Ioannou GN; Haigh WG; Yeh MM; Kowdley KV; O'Brien KD; Pennathur S; Chait A
J Lipid Res; 2011 Sep; 52(9):1626-35. PubMed ID: 21690266
[TBL] [Abstract][Full Text] [Related]
14. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ
Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664
[TBL] [Abstract][Full Text] [Related]
15. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
[TBL] [Abstract][Full Text] [Related]
16. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH.
Gäbele E; Dostert K; Hofmann C; Wiest R; Schölmerich J; Hellerbrand C; Obermeier F
J Hepatol; 2011 Dec; 55(6):1391-9. PubMed ID: 21703208
[TBL] [Abstract][Full Text] [Related]
17. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease.
Bieghs V; Van Gorp PJ; Wouters K; Hendrikx T; Gijbels MJ; van Bilsen M; Bakker J; Binder CJ; Lütjohann D; Staels B; Hofker MH; Shiri-Sverdlov R
PLoS One; 2012; 7(1):e30668. PubMed ID: 22295101
[TBL] [Abstract][Full Text] [Related]
18. Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation.
Bieghs V; Walenbergh SM; Hendrikx T; van Gorp PJ; Verheyen F; Olde Damink SW; Masclee AA; Koek GH; Hofker MH; Binder CJ; Shiri-Sverdlov R
Liver Int; 2013 Aug; 33(7):1056-61. PubMed ID: 23617943
[TBL] [Abstract][Full Text] [Related]
19. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
Rivera CA; Gaskin L; Allman M; Pang J; Brady K; Adegboyega P; Pruitt K
BMC Gastroenterol; 2010 May; 10():52. PubMed ID: 20509914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]